Left Arrow
Back

CHAI's Risk Categorization Tool (v3) Scores AI on 19 Named Risk Modifiers

CHAI's v3 Risk Categorization Tool scores healthcare AI across 19 named modifiers. Here's what that means for AI interpretation programs.

Eyal Heldenberg

Co-founder and CEO, building No Barrier

Last Updated:

July 22, 2026

7

Minute Read

CHAI released the third version of its Risk Categorization Tool in June 2026, developed by its Risk Work Group, replacing the single risk score of earlier drafts with nineteen individually rated modifiers across two domains. The tool now walks a health system through nineteen named risk modifiers: nine under Life & Patient Safety and ten under Technology & Data.
And each one gets its own low, medium or high read rather than being folded into a single composite number. There is no dashboard score at the end of this. What comes out is a map of where a use case needs a closer look and CHAI pushes hard toward a deeper follow-up review the moment even one modifier lands on the high end. For any AI tool sitting inside a live clinical conversation, that modifier-by-modifier structure matters more than a single risk score ever could.

1. Four Risk Phases, Only the First Is Covered Here

CHAI frames AI risk management as four connected phases, and this tool only handles the first one.

1.1 The Four Phases in Order

Risk Categorization classifies a use case as low, medium or high during pre-deployment and sets how much rigor everything downstream needs.

Risk Assessment follows for anything that lands high, a closer look sized to the organization's own appetite for risk.

Risk Mitigation is where controls actually get built and written down.

Risk Monitoring is the ongoing watch over performance and safety once a tool is live.

1.2 Where the Framework Stops Today

The v3 guide is candid about a real gap. CHAI has not yet published a formal Risk Assessment methodology for phase two and tells health systems to lean on their own process in the meantime. That is a maturity signal worth noting, a national coalition shipping a tiering tool before it has finished the harder layer underneath it, rather than sitting on the whole framework until it is complete.

2. Nine Modifiers Score How Close the AI Sits to the Patient

The Life & Patient Safety domain asks a reviewer to work through modifiers like:

  • Distance from Patient,
  • Decision Autonomy,
  • Consequences of Failure,
  • Use Context and Complexity,
  • React Time,
  • Breadth of Potential Harm,
  • Cross-System Propagation Risk
  • and Population Sensitivity or Disparity Risk.

2.1 Distance from Patient and Decision Autonomy

A single medical interpretation platform can score differently on the same modifier depending on the conversation it is carrying. Confirming a scheduling appointment in Spanish sits close to the low end of Distance from Patient, with a human still deciding what happens next. Walking a patient through informed consent for surgery does not sit there and Decision Autonomy shifts too, from a human clearly deciding to a human supervising a conversation happening in real time.

2.2 React Time and Breadth of Potential Harm

On Care Culture Talks, Dr. Sam Frenkel described how competing for scarce interpreter resources in the ER shapes triage decisions in ways nobody teaches in medical school. That is exactly the kind of pressure React Time and Breadth of Potential Harm are built to surface before go-live, not after a bad outcome, since an ER visit gives a clinician far less time to catch an interpretation error than a scheduled outpatient consult does.

3. Ten Modifiers Score What's Underneath the Model

The Technology & Data domain covers:

-  Use of Sensitive Data,

- Accuracy of Data,

- Completeness of Data,

- Veracity of Data,

- Data Transparency,

- Sufficiency and Representativeness of Data Used for AI Model Training and Operation,

- AI Model Security Vulnerabilities,

- AI Model Lifecycle Management and Updates,

- AI Monitoring and Incident Detection,

- plus AI Detection and Traceability. Two of these land squarely on interpretation platforms.

3.1 Sufficiency and Representativeness

This modifier asks whether training data cover the populations a tool will actually encounter, which is the same question as asking whether a platform's 295+ languages and dialects include enough Haitian Creole, Tagalog or regional Spanish variation to avoid gaps nobody notices until a patient does.

3.2 AI Detection and Traceability

This modifier asks whether a patient can tell when AI is influencing what they are hearing. That question sits close to what the 2026 NEJM Catalyst study of Spanish-speaking surgical patients at Brigham and Women's Hospital found: patients wanted AI for speed and privacy and a human interpreter for emotionally complex consults, which only works if the patient actually knows which one they are getting.

4. What CHAI's Own Worked Example Shows

CHAI's v3 guide includes a completed example rather than just a blank template, a scheduling chatbot used in outpatient, primary care settings.

4.1 The Scheduling Chatbot Scores Low

CHAI's own worked example walks an AI-assisted patient scheduling chatbot through the tool. Most modifiers come back low across the board. The reason is structural, not incidental. In this example, a human confirms the appointment once the AI finishes scheduling it. Decision Autonomy stays low because nothing happens without that final human step. Distance from Patient stays low because the tool never touches the clinical conversation itself.

4.2 Swap in Informed Consent and the Score Flips

Replace that same tool with an interpretation platform handling informed consent instead of scheduling and several modifiers move immediately. Distance from Patient moves toward high because the AI is now directly inside patient care, not adjacent to it. 

Population Sensitivity or Disparity Risk becomes central rather than an afterthought, since the patients affected are, by definition, the ones with limited English proficiency. That contrast is the entire point of scoring modifiers individually instead of asking one blanket question like "is this AI tool risky."

Bottom Line

CHAI's Risk Categorization Tool (v3) provides a framework that supports a health system's own judgment. Its nineteen modifiers exist to score risk at the level of how a tool actually gets used, not as a single number. The real test is not whether a vendor has read this framework. It is whether they can walk through all nineteen modifiers for their own product without backing off, before a governance committee ever asks them to.

FAQs

1. What is CHAI's Risk Categorization Tool (v3)?

Chevron

It is a pre-deployment screening tool from the Coalition for Health AI's Risk Work Group, released in June 2026. It scores a healthcare AI use case across 19 named risk modifiers, nine under Life & Patient Safety and ten under Technology & Data, each rated low, medium or high rather than combined into a single score.

2. How does a health system evaluate new AI tools before rolling them out?

Chevron

Health systems evaluating AI interpretation should look for a vendor built specifically for healthcare, not a general purpose translation tool adapted after the fact. No Barrier for instance is HIPAA and SOC 2 Type II certified, with human oversight and audit logs, covering 295+ language access options across intake, encounter and follow up so committees are not left stitching together several point solutions to meet clinical and compliance needs.

3. How to decide between AI and human interpretation?

Chevron

The decision does not need to be binary. No Barrier offers 295+ language access options within one interface, so patients and providers choose based on comfort level and the nature of the conversation rather than switching tools or devices, from intake to follow-up.

4. What equipment does AI interpretation require in a clinic setting?

Chevron

No Barrier requires no new hardware, working on existing kiosks, laptops or tablets a clinic already has in place. Some health systems choose to add dedicated iPads for patient facing use, but that is a preference for availability, not a technical requirement, which keeps implementation lightweight for any health center regardless of budget.

Chevron
Author Image
Eyal Heldenberg

Co-founder and CEO, building No Barrier

Eyal has 20+ years in speech-to-speech and voice AI and is the co-founder of No Barrier AI, a HIPAA-compliant medical interpreter platform. Over the past two years, he has led its adoption across healthcare organizations, helping providers bridge dialect gaps, reduce compliance risk and improve patient safety. His mission is simple: ensure health equity by removing language barriers at the point of care.

Share this article

Linkedin

No Barrier - AI Medical Interpreter

Zero waiting time, state-of-the-art medical accuracy, HIPAA compliant